Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Pharmacology|January 1, 1978
Plasma levels and protein binding of phenytoin during exercise in man: the effect of elevated free fatty acidsO Borgå, A Juhlin-Dannfeldt, R DahlqvistEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 18, 2001
The role of P-glycoprotein in limiting intestinal regional absorption of digoxin in ratsM Sababi, O Borgå, U Hultkvist-BengtssonPharmacology & Toxicology|May 1, 1987
Effects of ampicillin on the elimination of enprofylline in manO Paulsen, O Borgå, K E AnderssonClinical Pharmacokinetics|November 1, 1976
Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsyN Barth, G Alván, O Borgå, et al.British Journal of Clinical Pharmacology|March 1, 1983
Effect of cephapirin on tubular reabsorption of amino acids, uric acid and beta 2-microglobulin in manA Arvidsson, G Alván, O Borgå, et al.Die Pharmazie|August 22, 2009
Grapefruit juice interaction with oral budesonide: equal effect on immediate-release and delayed-release formulationsJ Seidegård, G Randvall, L Nyberg, et al.Clinical Pharmacology and Therapeutics|November 1, 1977
Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphateO Borgå, K M Piafsky, O G NilsenTherapeutic Drug Monitoring|January 1, 1989
Distribution of enprofylline and theophylline between plasma and cerebrospinal fluidL C Laursen, O Borgå, L Krohn, et al.Therapeutic Drug Monitoring|January 1, 1988
Transfer of enprofylline into breast milkL C Laursen, O Borgå, K Ljungholm, et al.Clinical Pharmacology and Therapeutics|September 1, 1979
Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failureO Borgå, C Hoppel, I Odar-Cederlöf, et al.Pageof 4